Skip to main content
. 2017 Jul 18;32(1):968–977. doi: 10.1080/14756366.2017.1347163

Table 3.

Predicted pharmacokinetic properties of compounds 1, 3, 14, 15 and 16.

Compound AlogP98 PSA-2D Solubility level Absorption level BBB level PPB CYP2D6
1 3.647 68.259 2 0 2 True True
3 4.532 47.443 2 0 1 True True
14 3.664 59.328 2 0 1 True True
15 3.208 59.328 2 0 2 True True
16 4.945 50.796 2 0 1 True False
G 4.267 47.443 2 0 1 True True

AlogP98: Lipophilicity descriptor; PSA-2D: Polar surface area; AlogP98: Lipophilicity descriptor; PSA-2D: Polar surface area; Solubility Level: (0, Good; 1, Moderate; 2, Poor; 3, Very poor); Absorption Level: (0, Good; 1, Moderate; 2, Poor; 3, Very poor); BBB Level: (0, very high blood–brain barrier penetration; 1, high; 2, medium; 3, low).